Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Cancer research meets evolutionary biology.

Pepper JW, Scott Findlay C, Kassen R, Spencer SL, Maley CC.

Evol Appl. 2009 Feb;2(1):62-70. doi: 10.1111/j.1752-4571.2008.00063.x.

2.

A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.

Merlo LM, Shah NA, Li X, Blount PL, Vaughan TL, Reid BJ, Maley CC.

Cancer Prev Res (Phila). 2010 Nov;3(11):1388-97. doi: 10.1158/1940-6207.CAPR-10-0108. Epub 2010 Oct 12.

3.

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.

4.

Analysis of genetic inheritance in a family quartet by whole-genome sequencing.

Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L, Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB, Hood L, Galas DJ.

Science. 2010 Apr 30;328(5978):636-9. doi: 10.1126/science.1186802. Epub 2010 Mar 10.

5.

The landscape of somatic copy-number alteration across human cancers.

Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M.

Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.

6.

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.

Reid BJ, Li X, Galipeau PC, Vaughan TL.

Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773. Review.

7.

History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK.

Gastroenterology. 2010 Mar;138(3):854-69. doi: 10.1053/j.gastro.2010.01.002. Epub 2010 Jan 18. Review.

8.

Radiofrequency ablation in Barrett's esophagus with dysplasia.

Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ.

N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145.

9.

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.

Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ.

Clin Cancer Res. 2009 May 15;15(10):3305-14. doi: 10.1158/1078-0432.CCR-08-2494. Epub 2009 May 5.

10.

Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.

Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z.

Gastroenterology. 2009 Aug;137(2):588-97. doi: 10.1053/j.gastro.2009.04.046. Epub 2009 Apr 23.

11.

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.

Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A.

Br J Cancer. 2009 Feb 10;100(3):551-7. doi: 10.1038/sj.bjc.6604880. Epub 2009 Jan 20.

12.

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.

Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, Arnaudo J, Peiffer DA, Pokholok D, Gunderson KL, Reid BJ.

Cancer Prev Res (Phila). 2008 Nov;1(6):413-23. doi: 10.1158/1940-6207.CAPR-08-0121.

13.

Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.

Blaser MJ.

Cancer Prev Res (Phila). 2008 Oct;1(5):308-11. doi: 10.1158/1940-6207.CAPR-08-0170. No abstract available.

14.

Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus.

Lao-Sirieix P, Corovic A, Jankowski J, Lowe A, Triadafilopoulos G, Fitzgerald RC.

Dis Esophagus. 2008;21(6):529-38. doi: 10.1111/j.1442-2050.2007.00807.x.

PMID:
18840137
15.

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L.

Am J Epidemiol. 2008 Aug 1;168(3):237-49. doi: 10.1093/aje/kwn121. Epub 2008 Jun 12. Review.

PMID:
18550563
16.

The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.

Jenkins GJ, Cronin J, Alhamdani A, Rawat N, D'Souza F, Thomas T, Eltahir Z, Griffiths AP, Baxter JN.

Mutagenesis. 2008 Sep;23(5):399-405. doi: 10.1093/mutage/gen029. Epub 2008 May 30.

PMID:
18515815
17.

High risk of malignancy in familial Barrett's esophagus: presentation of one family.

Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro LF, Yelamos J, Molina J.

J Clin Gastroenterol. 2008 Aug;42(7):806-9. doi: 10.1097/MCG.0b013e3180329015.

PMID:
18385604
18.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Wang KK, Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology.

Am J Gastroenterol. 2008 Mar;103(3):788-97. doi: 10.1111/j.1572-0241.2008.01835.x. No abstract available.

PMID:
18341497
19.

Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus.

Leedham SJ, Preston SL, McDonald SA, Elia G, Bhandari P, Poller D, Harrison R, Novelli MR, Jankowski JA, Wright NA.

Gut. 2008 Aug;57(8):1041-8. doi: 10.1136/gut.2007.143339. Epub 2008 Feb 27.

20.

A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.

van Baal JW, Milana F, Rygiel AM, Sondermeijer CM, Spek CA, Bergman JJ, Peppelenbosch MP, Krishnadath KK.

Cell Oncol. 2008;30(1):63-75.

Supplemental Content

Support Center